Literature DB >> 33856620

Fluorescence Determination of Peptidase Activity Based on the Quenching of a Fluorophore-Labelled Peptide by Graphene Oxide.

Dinh-Vu Le1.   

Abstract

In this study, a fluorescence detection strategy is reported for the peptidase activity assay, which is based on fluorescence resonance energy transfer (FRET) from a fluorophore-labelled peptide to graphene oxide (GO). By the hydrolysis of the peptide, the fluorophore-labelled peptide releases the fluorophore 5-carboxyfluorescein, which can avoid quenching from GO. Thus, the increased intensity of the obtained fluorescence signal in the assay is directly dependent on the peptidase activity. As a model case of the developed strategy, the activity determination of pancreatic elastase (PE) is performed. Under the optimal experimental conditions at an excitation wavelength of 494 nm, the activity of PE can be determined in the range from 0.003 to 0.10 U/mL, with a detection limit of 0.001 U/mL at the emission wavelength of 518 nm. This is ultra-sensitive for the determination of PE. The specificity of the method is demonstrated by the analysis of PE under complex conditions using fetal bovine serum as the substrate. Hence, the developed method might provide an intrinsically convenient, sensitive platform for the PE activity assay and related biochemical studies due to its homogeneous, and fluorescence-based detection strategy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Fluorescence quenching; Graphene oxide; Pancreatic elastase; Peptidase

Mesh:

Substances:

Year:  2021        PMID: 33856620     DOI: 10.1007/s10930-021-09985-6

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  24 in total

Review 1.  Signal peptidases.

Authors:  Mark Paetzel; Andrew Karla; Natalie C J Strynadka; Ross E Dalbey
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.

Authors:  Zubair Shah; Thomas Kampfrath; Jeffrey A Deiuliis; Jixin Zhong; Colleen Pineda; Zhekang Ying; Xiaohua Xu; Bo Lu; Susan Moffatt-Bruce; Rekha Durairaj; Qinghua Sun; Georgeta Mihai; Andrei Maiseyeu; Sanjay Rajagopalan
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

Review 3.  Wound healing effects of dipeptidyl peptidase-4 inhibitors: An emerging concept in management of diabetic foot ulcer-A review.

Authors:  Apoorva Saboo; Ayeshmanthe Rathnayake; Venkat N Vangaveti; Usman H Malabu
Journal:  Diabetes Metab Syndr       Date:  2015-04-25

4.  Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk.

Authors:  Ping Yang; William R Bamlet; Zhifu Sun; Jon O Ebbert; Marie-Christine Aubry; Michael J Krowka; William R Taylor; Randolph S Marks; Claude Deschamps; Stephen J Swensen; Eric D Wieben; Julie M Cunningham; Lee Joseph Melton; Mariza de Andrade
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

Review 5.  Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases.

Authors:  Weijia Xie; Xiaoxiao Song; Zhenjie Liu
Journal:  Vascul Pharmacol       Date:  2018-06-04       Impact factor: 5.773

6.  The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

Authors:  Gian Paolo Fadini; Elisa Boscaro; Mattia Albiero; Lisa Menegazzo; Vera Frison; Saula de Kreutzenberg; Carlo Agostini; Antonio Tiengo; Angelo Avogaro
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 19.112

7.  Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.

Authors:  Veerle Matheeussen; Yannick Waumans; Wim Martinet; Sebastiaan Van Goethem; Pieter Van der Veken; Simon Scharpé; Koen Augustyns; Guido R Y De Meyer; Ingrid De Meester
Journal:  Basic Res Cardiol       Date:  2013-04-23       Impact factor: 17.165

8.  Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

Authors:  C Morimoto; C I Lord; C Zhang; J S Duke-Cohan; N L Letvin; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 9.  Degrade to create: developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis.

Authors:  Bruce Bowerman; Thimo Kurz
Journal:  Development       Date:  2006-03       Impact factor: 6.868

10.  Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence.

Authors:  Deanna A Mele; Pradeep Bista; Diana Velez Baez; Brigitte T Huber
Journal:  Cell Cycle       Date:  2009-08-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.